Clinical trial results support strategy for reversing type 1 diabetes
A phase I clinical trial has confirmed that use of a generic vaccine to raise levels of an immune system modulator can cause the death of autoimmune cells targeting the insulin-secreting cells of the pancreas and temporarily ...
Aug 8, 2012
0
0